Press release
Deadline on March 21st coming up in Lawsuit for Investors in NRx Pharmaceuticals, Inc. (NASDAQ: NRXP)
A Deadline is coming up on March 21, 2022in the lawsuit for certain investors in NRx Pharmaceuticals, Inc. (NASDAQ: NRXP).
Investors who purchased shares of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) have certain options and there are strict and short deadlines running. Deadline: March 21, 2022. NASDAQ: NRXP stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the District of Delaware the plaintiff alleges on behalf of purchasers of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) common shares between June 1, 2021 and November 4, 2021, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between June 1, 2021 and November 4, 2021, the Defendants made materially false and misleading statements regarding the Company's business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the ZYESAMI EUA Application contained insufficient data regarding the potential benefits and risks of ZYESAMI; (ii) accordingly, the FDA was unlikely to approve the ZYESAMI EUA Application in its present form; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on March 21st coming up in Lawsuit for Investors in NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) here
News-ID: 2574423 • Views: …
More Releases from Shareholders Foundation
Investors in Thoughtworks Holding, Inc. (NASDAQ: TWKS) should contact the Shareh …
An investigation was announced concerning whether the takeover of Thoughtworks Holding, Inc. is unfair to NASDAQ: TWKS stockholders.
Investors who purchased shares of Thoughtworks Holding, Inc. (NASDAQ: TWKS) and currently hold any of those NASDAQ: TWKS shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain officers and directors of Thoughtworks Holding, Inc. breached their…
Investigation announced for Investors who lost money with shares of Domino's Piz …
An investigation was announced for investors of Domino's Pizza, Inc. (NYSE: DPZ) shares over potential securities laws violations by Domino's Pizza, Inc.
Investors who purchased shares of Domino's Pizza, Inc. (NYSE: DPZ), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Domino's Pizza, Inc. (NYSE: DPZ)…
Investigation announced for Long-Term Investors in shares of Ocugen, Inc. (NASDA …
An investigation was announced over potential breaches of fiduciary duties by certain directors and officers of Ocugen, Inc.
Investors who are current long term investors in Ocugen, Inc. (NASDAQ: OCGN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: OCGN stocks follows a lawsuit filed against Ocugen, Inc. over alleged…
Investigation announced for Investors who lost money with shares of Dayforce Inc …
An investigation was announced for investors of Dayforce Inc (NYSE: DAY) shares over potential securities laws violations by Dayforce Inc.
Investors who purchased shares of Dayforce Inc (NYSE: DAY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Dayforce Inc regarding its business, its prospects and its operations were materially…
More Releases for NASDAQ:
Zillow Group, Inc. (NASDAQ: Z, NASDAQ: ZG) Investor Notice: Update in Lawsuit ag …
The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in Zillow Group, Inc. (NASDAQ: Z, NASDAQ: ZG).
Investors who purchased shares of Zillow Group, Inc. (NASDAQ: Z, NASDAQ: ZG) and currently hold any of those NASDAQ: MTCH shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On November 16, 2021, a lawsuit was filed against Zillow Group,…
Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK) Investor Alert: Deadline in Lawsu …
A deadline is coming up on March 8, 2022in the lawsuit filed for certain investors of Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK) over alleged securities laws violations by Goldman Sachs and Morgan Stanley
Investors who purchased shares of Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK) have certain options and there are strict and short deadlines running. Deadline: March 8, 2022. Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK) stockholders should contact the Shareholders Foundation…
Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK) Investor Notice: Lawsuit alleges …
An investor, who purchased shares of Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK), filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws.
Investors who purchased a significant amount of shares of Discovery, Inc. (NASDAQ: DISCA, NASDAQ: DISCK) between March 22, 2021 and March 29, 2021, have certain options and for certain investors are short and strict deadlines running. Deadline:…
Investigation for NASDAQ: FREQ Investors over possible Wrongdoing at Frequency T …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Frequency Therapeutics, Inc.
Investors who purchased shares of Frequency Therapeutics, Inc. (NASDAQ: FREQ) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Frequency Therapeutics, Inc. (directors breached their fiduciary duties and caused damage to the company and its shareholders.
Woburn,…
Investigation announced for Investors in shares of Alphabet Inc. (NASDAQ: GOOG, …
An investigation was announced on behalf of investors of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL) shares over potential securities laws violations by Alphabet Inc. in connection with certain financial statements.
Investors who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers…
Oncolytic Virus Therapy Market 2020 Research and Clinical Analysis - Amgen(NASDA …
"Global Oncolytic Virus Therapy Market Report 2020-2026" helps the clients to take business decisions and to understand strategies of major players in the industry. The report also calls for market - driven results deriving feasibility studies for client needs. Marketinsightsreports ensures qualified and verifiable aspects of market data operating in the real- time scenario. The analytical studies are conducted ensuring client needs with a thorough understanding of market capacities in…
